| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6413549 | SALIX PHARMS | Fast-Dispersing solid oral dosage form containing coarse particles |
Jul, 2017
(6 years ago) | |
Metozolv Odt is owned by Salix Pharms.
Metozolv Odt contains Metoclopramide Hydrochloride.
Metozolv Odt has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Metozolv Odt are:
- US6413549
Metozolv Odt was authorised for market use on 04 September, 2009.
Metozolv Odt is available in tablet, orally disintegrating;oral dosage forms.
The generics of Metozolv Odt are possible to be released after 11 July, 2017.
Drugs and Companies using METOCLOPRAMIDE HYDROCHLORIDE ingredient
Market Authorisation Date: 04 September, 2009
Treatment: NA
Dosage: TABLET, ORALLY DISINTEGRATING;ORAL
How can I launch a generic of METOZOLV ODT before it's drug patent expiration?
More Information on Dosage
METOZOLV ODT family patents
